188 related articles for article (PubMed ID: 2578552)
1. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
Rombaut B; Vrijsen R; BoeyƩ A
J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
[TBL] [Abstract][Full Text] [Related]
2. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
[TBL] [Abstract][Full Text] [Related]
4. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
5. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
[TBL] [Abstract][Full Text] [Related]
6. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
7. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
Emini EA; Ostapchuk P; Wimmer E
J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
[TBL] [Abstract][Full Text] [Related]
8. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
Emini EA; Jameson BA; Lewis AJ; Larsen GR; Wimmer E
J Virol; 1982 Sep; 43(3):997-1005. PubMed ID: 6183443
[TBL] [Abstract][Full Text] [Related]
10. Antigenic characterization of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Spitz M; Schild GC
Rev Infect Dis; 1984; 6 Suppl 2():S510-3. PubMed ID: 6204368
[TBL] [Abstract][Full Text] [Related]
11. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
12. Characterization and assembly of poliovirus-related 45 S particles.
Rombaut B; Vrijsen R; Delgadillo R; Vanden Berghe D; BoeyƩ A
Virology; 1985 Oct; 146(1):111-9. PubMed ID: 2412342
[TBL] [Abstract][Full Text] [Related]
13. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
Uhlig H; Haardt F; Dernick R
Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
[TBL] [Abstract][Full Text] [Related]
14. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E
Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073
[TBL] [Abstract][Full Text] [Related]
15. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
Wiegers KJ; Dernick R
J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
[TBL] [Abstract][Full Text] [Related]
16. Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus.
Ferguson M; Minor PD
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1271-4. PubMed ID: 1693661
[TBL] [Abstract][Full Text] [Related]
17. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
Uhlig H; Rutter G; Dernick R
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
[TBL] [Abstract][Full Text] [Related]
18. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
19. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
20. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.
Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F
Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]